- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CliniComp debuts repository for clinical data integration
CliniComp debuts repository for clinical data integrationClinical information systems developer CliniComp is now marketing the Global Data Repository, a relational database designed to enable clinical information integration and provide the
CliniComp debuts repository for clinical data integration
Clinical information systems developer CliniComp is now marketing the Global Data Repository, a relational database designed to enable clinical information integration and provide the foundation for computer-based patient records. The GDR is an adjunct to the CliniComp CIS, which maintains two copies of data on separate CIS servers to enhance data redundancy and creation of CPRs. The Oracle-based GDR acts as an additional database to map data from disparate information systems. It is already being made available to Flagstaff Medical Center (AZ), Kapi'olani Medical Center (Honolulu), Walter Reed Army Medical Center (Washington, DC), and Dewitt Army Community Hospital (Washington, DC).
- Search Again
- Return To HNN Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
